Evidence map›Paper›PMID 38169584›Full record

ArticleInternational journal of biological sciences2024

ADAR1 protects pulmonary macrophages from sepsis-induced pyroptosis and lung injury through miR-21/A20 signaling.

Xiaojun Zhao, Jiangang Xie, Chujun Duan, Linxiao Wang, Yi Si, Shanshou Liu, Qianmei Wang, Dan Wu, Yifan Wang, Wen Yin and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of biological sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Itaconate alleviates LPS-induced septic liver injury by regulating ROS-PAD4-mediated macrophages extracellular traps through Nrf2.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Xiaojun ZhaoDepartment of Emergency, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Jiangang XieDepartment of Emergency, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Chujun DuanDepartment of Emergency, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Linxiao WangCollege of Life Sciences, Northwest University, Xi'an, China.
Yi SiDepartment of Emergency, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Shanshou LiuDepartment of Emergency, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Qianmei WangDepartment of Emergency, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Dan WuDepartment of Emergency, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Yifan WangDepartment of Emergency, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Wen YinDepartment of Emergency, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Ran ZhuangDepartment of Immunology, Fourth Military Medical University, Xi'an, China.
Junjie LiDepartment of Emergency, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Air Force Medical University · CNXijing Hospital · CNNorthwest University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute lung injury is a serious complication of sepsis with high morbidity and mortality. Pyroptosis is a proinflammatory form of programmed cell death that leads to immune dysregulation and organ dysfunction during sepsis. We previously found that adenosine deaminase acting on double-stranded RNA 1 (ADAR1) plays regulatory roles in the pathology of sepsis, but the mechanism of ADAR1 in sepsis-induced pyroptosis and lung injury remains unclear. Here, we mainly investigated the regulatory effects and underlying mechanism of ADAR1 in sepsis-induced lung injury and pyroptosis of pulmonary macrophages through RNA sequencing of clinical samples, caecal ligation and puncture (CLP)-induced septic mouse models, and in vitro cellular experiments using RAW264.7 cells with lipopolysaccharide (LPS) stimulation. The results showed that pyroptosis was activated in peripheral blood mononuclear cells (PBMCs) from patients with sepsis. In the CLP-induced septic mouse model, pyroptosis was mainly activated in pulmonary macrophages. LPS-stimulated RAW264.7 cells showed significantly increased activation of the NLRP3 inflammasome. ADAR1 was downregulated in PMBCs of patients with sepsis, and overexpression of ADAR1 alleviated CLP-induced lung injury and NLRP3 inflammasome activation. Mechanistically, the regulatory effects of ADAR1 on macrophage pyroptosis were mediated by the miR-21/A20/NLRP3 signalling cascade. ADAR1 attenuated sepsis-induced lung injury and hindered the activation of pyroptosis in pulmonary macrophages in sepsis through the miR-21/A20/NLRP3 axis. Our study highlights the role of ADAR1 in protecting pulmonary macrophages against pyroptosis and suggests targeting ADAR1/miR-21 signalling as a therapeutic opportunity in sepsis-related lung injury.

Indexed as

Acute Lung InjuryMicroRNAsSepsisAdenosine DeaminaseAnimalsDisease Models, AnimalHumansInflammasomesLeukocytes, MononuclearLipopolysaccharidesMacrophages, AlveolarMiceNLR Family, Pyrin Domain-Containing 3 ProteinPyroptosisRNA-Binding ProteinsADAR1 protein, mouseADAR protein, humanAdenosine DeaminaseInflammasomesLipopolysaccharidesMicroRNAsMIRN21 microRNA, humanNLR Family, Pyrin Domain-Containing 3 ProteinRNA-Binding ProteinsA20ADAR1lung injurymacrophagepyroptosissepsis

Identifiers

PMID38169584
PMCPMC10758098
OpenAlexW4389340062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.